BackAscendis Pharma A/S Overview

Ascendis Pharma A/S Receivables

Latest receivables for ASND: $220M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$224.01M
↑ 102.81% YoYΔ $113.56M vs prior year quarter

Peer trimmed avg / median

Loading

Ascendis Pharma A/S Receivables History

Loading

Ascendis Pharma A/S vs. peers: Receivables Comparison

Loading

Ascendis Pharma A/S Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ascendis Pharma A/S (ASND) FAQ

As of the most recent data (June 2026), ASND shows a receivables of $220M. That compares with $110M in the prior-year period — up 102.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASND's receivables is now $220M (was $110M) — a 102.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ascendis Pharma A/S is outperforming or lagging.

Tracking ASND's receivables over time shows whether Ascendis Pharma A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $220M That compares with $110M in the prior-year period — up 102.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Ascendis Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $220M) with ownership activity and broader fundamentals.

Ascendis Pharma A/S's receivables is $220M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.